Tempus AI is trading at $49.26 (6.1% down) amid continued weakness in high-growth AI and healthcare technology stocks.
- The decline extends a multi-session slide following muted 2026 guidance and an ongoing investor rotation out of expensive AI names into more defensive sectors.
- The stock remains under pressure even as broader indices rebound, highlighting company- and sector-specific concerns regarding the valuation of Tempus AI.